On This Page
Publications and Reports
CDC’s CKD Initiative
Albright A, Burrows NR, Jordan R, Williams DE.
The Kidney Disease Initiative and the Division of Diabetes Translation
at the Centers for Disease Control and Prevention. [PDF–160KB] Am
J Kidney Dis.
2009;53(3 Suppl 3):S121–5.
Narva AS, Briggs M, Jordan R, Pavkov ME, Burrows NR, Williams DE. Toward a more collaborative federal response to chronic kidney disease. Adv Chronic Kidney Dis. 2010;17(3):282−288.
Principles and Data Sources for CKD Surveillance
Schoolwerth AC, Engelgau MM, Hostetter TH, Rufo KH, Chianchiano D,
McClellan WM, Warnock DG, Vinicor F.
Chronic kidney disease: a public health
problem that needs a public health action plan. [PDF–191KB]
Prev Chronic Dis.
2006;3(2):A57.
Levey AS, Schoolwerth, AC, Burrows NR, Williams DE, Stith KR, McClellan W. Comprehensive public health strategies for preventing the development, progression, and complications of CKD: report of an expert panel convened by the Centers for Disease Control and Prevention. Am J Kidney Dis. 2009;53(3):522−535.
Powe NR, Plantinga L, Saran R. Public health surveillance of CKD: principles, steps, and challenges. [PDF–357KB] Am J Kidney Dis. 2009;53(3 Suppl 3):S37−S45.
Saran R, Hedgeman E, Plantinga L, Burrows NR, Gillespie BW, Young EW, Coresh J, Pavkov M, Williams D, Powe NR; for the CKD Surveillance Team. Establishing a national chronic kidney disease surveillance system for the United States. [PDF-110KB] Clin J Am Soc Nephrol. 2010;5(1):152−161.
Grams ME, Plantinga LC, Hedgeman E, Saran R, Myers GL, Williams DE, Powe NR; CDC CKD Surveillance Team. Validation of CKD and related conditions in existing data sets: A systematic review. Am J Kidney Dis. 2011;57(1):44–54. Epub 2010 Aug 6. Review.
Prevalence of CKD
Plantinga LC, Crews DC, Coresh J,
Miller ER III, Saran R, Yee J, Hedgeman E, Pavkov M, Eberhardt MS,
Williams DE, Powe NR; CDC CKD Surveillance Team.
Prevalence of
chronic kidney disease in U.S. adults with undiagnosed diabetes or prediabetes.[PDF-124KB] Clin J Am Soc Nephrol. 2010;5(4):673−682.
Crews DC, Plantinga LC, Miller ER III, Saran R, Hedgeman E, Saydah SH, Williams DE, Powe NR; Centers for Disease Control and Prevention Chronic Kidney Disease Surveillance Team. Prevalence of chronic kidney disease in persons with undiagnosed or prehypertension in the United States. Hypertension. 2010;55(5):1102−1109.
Awareness of CKD
Tuot DS, Plantinga LC, Hsu CY, Jordan R,
Burrows NR, Hedgeman E, Yee J, Saran R, Powe NR; Centers for Disease
Control Chronic Kidney Disease Surveillance Team.
Chronic kidney disease awareness among
individuals with clinical markers of kidney dysfunction.
Clin J Am Soc Nephrol. 2011;6(8):1838–44.
Plantinga LC, Tuot DS, Powe NR. Awareness of chronic kidney disease among patients and providers. [PDF-226KB] Adv Chronic Kidney Dis. 2010;17(3):225–36.
Plantinga LC, Boulware LE, Coresh J, Stevens LA, Miller ER 3rd, Saran R, Messer KL, Levey AS, Powe NR. Patient awareness of chronic kidney disease: trends and predictors. [PDF–986KB] Arch Intern Med. 2008;168(20):2268–2275.
CKD complications and risk factors
Plantinga L, Grubbs V, Sarkar U, Hsu CY, Hedgeman E, Robinson B, Saran R, Geiss L, Burrows NR, Eberhardt M, Powe N; CDC CKD Surveillance Team. Nonsteroidal anti-inflammatory drug use among persons with chronic kidney disease in the United States. [PDF-333KB] Ann Fam Med. 2011;9(5):423–30.
Plantinga L, Lee K, Inker LA, Saran R, Yee J, Gillespie B, Rolka D, Saydah S, Powe NR; CDC CKD Surveillance Team. Association of sleep-related problems with CKD in the United States, 2005-2008. [PDF-597KB] Am J Kidney Dis. 2011;58(4):554–64.
Grubbs V, Plantinga LC, Crews DC, Bibbins-Domingo K, Saran R, Heung M, Patel PR, Burrows NR, Ernst KL, Powe NR; Centers for Disease Control and Prevention CKD Surveillance Team. Vulnerable populations and the association between periodontal and chronic kidney disease. Clin J Am Soc Nephrol. 2011;6(4):711–7. Epub 2011 Feb 24.
Plantinga LC, Johansen K, Crews DC, Shahinian VB, Robinson BM, Saran R, Burrows NR, Williams DE, Powe NR; CDC CKD Surveillance Team. Association of CKD with disability in the United States. Am J Kidney Dis. 2011;57(2):212–27.
Plantinga LC, Miller ER III, Stevens LA, Saran R, Messer K, Flowers N, Geiss L, Powe NR; Centers for Disease Control and Prevention Chronic Kidney Disease Surveillance Team. Blood pressure control among persons without and with chronic kidney disease: US trends and risk factors 1999–2006.[PDF-375KB] Hypertension. 2009;54(1):47–56.
Natural history of CKD
O'Hare AM, Batten A, Burrows NR, Pavkov
ME, Taylor L, Gupta I, Todd-Stenberg J, Maynard C,
Rodriguez RA, Murtagh FE, Larson EB, Williams DE.
Trajectories of kidney function decline in the 2 years
before initiation of long-term dialysis. Am J
Kidney Dis. [serial online] 2012. In press.
O'Hare AM, Hailpern SM, Pavkov ME, Rios-Burrows N, Gupta I, Maynard C, Todd-Stenberg J, Rodriguez RA, Hemmelgarn BR, Saran R, Williams DE. Prognostic implications of the urinary albumin to creatinine ratio in veterans of different ages with diabetes. Arch Intern Med. 2010;170(11):930−936.
Cost-effectiveness of CKD interventions
Hoerger TJ, Wittenborn JS, Segel JE, Burrows NR, Imai K, Eggers P,
Pavkov ME, Jordan R, Hailpern SM, Schoolwerth AC, Williams DE;
Centers for Disease Control and Prevention CKD Initiative.
A health policy model of CKD: 1. model
construction, assumptions, and validation of health consequences. [PDF–457KB]
Am J Kidney Dis. 2010;55(3):452–62.
Hoerger TJ, Wittenborn JS, Segel JE, Burrows NR, Imai K, Eggers P, Pavkov ME, Jordan R, Hailpern SM, Schoolwerth AC, Williams DE; Centers for Disease Control and Prevention CKD Initiative. A health policy model of CKD: 2. The cost-effectiveness of microalbuminuria screening. [PDF–831KB] Am J Kidney Dis. 2010;55(3):463–73.
Screening for CKD
Vassalotti JA, Fox CH, Becker BN.
Risk factors and screening for chronic
kidney disease. Adv Chronic Kidney Dis. 2010;17(3):237–45.
Collins AJ, Vassalotti JA, Wang C, Li S, Gilbertson DT, Liu J, Foley RN, Chen SC, Arneson TJ. Who should be targeted for CKD screening? Impact of diabetes, hypertension, and cardiovascular disease. [PDF–337KB] Am J Kidney Dis. 2009;53(3 Suppl 3):S71–7.
Morbidity and Mortality Weekly Reports (MMWRs)
Incidence of End-Stage Renal Disease Among Persons with Diabetes—United States, 1990–2002
Prevalence of Chronic Kidney Disease and Associated Risk Factors United States, 1999–2004
State-Specific Trends in Chronic Kidney Failure—United States, 1990–2001
Hospitalization Discharge Diagnoses for Kidney Disease—United States, 1980–2005
Kidney Disease Mortality—Michigan, 1989–2005
Reducing Bloodstream Infections in an Outpatient Hemodialysis Center — New Jersey, 2008–2011
Vital Signs: Central Line–Associated Blood Stream Infections—United States, 2001, 2008, and 2009
Hepatitis C Virus Transmission at an Outpatient Hemodialysis Unit—New York, 2001–2008
Acute Allergic-Type Reactions Among Patients Undergoing Hemodialysis—Multiple States, 2007–2008
Contact Us:
- CDC Diabetes Public Inquiries
- 800-CDC-INFO
(800-232-4636)
TTY: (888) 232-6348
8am-8pm ET
Monday-Friday
Closed Holidays - cdcinfo@cdc.gov
